Real-world variability in ranibizumab treatment and associated clinical, quality of life, and safety outcomes over 24 months in patients with neovascular age-related macular degeneration: the HELIOS study

INTRODUCTION: The aim of this study was to examine ranibizumab treatment patterns in “real-world” practice and clinical settings, as well as to assess quality of life outcomes over a 24-month period. MATERIALS AND METHODS: This was a prospective, observational, multicenter, open-label study of 0.5 m...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Rakic, Jean-Marie, Leys, Anita, Brié, Heidi, Denhaerynck, Kris, Pacheco, Christy, Vancayzeele, Stefaan, Hermans, Christine, MacDonald, Karen, Abraham, Ivo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2013
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3788820/
https://ncbi.nlm.nih.gov/pubmed/24092964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S49385
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller